Details for New Drug Application (NDA): 085231
✉ Email this page to a colleague
NDA 085231 describes PYRILAMINE MALEATE, which is a drug marketed by Impax Labs and Watson Labs and is included in two NDAs. Additional details are available on the PYRILAMINE MALEATE profile page.
The generic ingredient in PYRILAMINE MALEATE is pyrilamine maleate. There are seven drug master file entries for this compound. Additional details are available on the pyrilamine maleate profile page.
The generic ingredient in PYRILAMINE MALEATE is pyrilamine maleate. There are seven drug master file entries for this compound. Additional details are available on the pyrilamine maleate profile page.
Summary for 085231
| Tradename: | PYRILAMINE MALEATE |
| Applicant: | Watson Labs |
| Ingredient: | pyrilamine maleate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085231
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
